IBRX News and Press, ImmunityBio Inc. From 07/10/23

ImmunityBio, Inc. (NASDAQ: IBRX ), a clinical-stage immunotherapy company, today announced findings from a Phase 1 study showing that allogeneic cytokine-induced memory-like (CIML) natural killer (NK) cells used in combination with ImmunityBio’s IL-15 superagonist N-803 may induce tumo...

2023-07-01 09:30:00 ET Get ahead of the market by subscribing to Seeking Alpha's Stocks to Watch, a preview of key events scheduled for the coming week. The newsletter keeps you informed of the biggest stories set to make headlines, including upcoming IPOs, investor days, earnings reports a...

2023-06-25 07:30:00 ET Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha , iTunes , Stitcher and Spotify . For further details see: Wall Street Breakfast: The Week Ahead

2023-06-24 10:30:00 ET Get ahead of the market by subscribing to Seeking Alpha's Stocks to Watch, a preview of key events scheduled for the coming week. The newsletter keeps you informed of the biggest stories set to make headlines, including upcoming IPOs, investor days, earnings reports a...

2023-06-23 15:00:37 ET Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Check out Saturday morning's regular Stocks to Watch article for a full list of events planned for the week or the Seeking Alpha earnings calendar ...

2023-06-20 00:48:21 ET Summary The FDA rejected the Anktiva marketing application last month. Since the troubles lie with an outside organization, the company has no control over the resolution. The drug is good, so resubmission, approval, and partnership are all still in play...

2023-06-12 11:29:52 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips There are some similarities between gambling and buying high-risk, high-reward stocks. In both scenarios, you could make a great deal of money or you could lose all of it. With this list of the...

2023-06-06 15:20:52 ET Penny stocks are often characterized by their high volatility. Their low price means that even small price changes can equate to significant percentage gains or losses. For instance, a $0.50 increase on a $1 stock equates to a 50% return. This potential for rapid and ...

ImmunityBio, Inc. ( NASDAQ: IBRX ), a clinical-stage immunotherapy company, today announced that Executive Chairman and Global Chief Scientific and Medical Officer Dr. Patrick Soon-Shiong, M.D., will participate in a fireside chat at the Jefferies Global Healthcare Conference on Wednesday, Ju...

ATLANTA, May 18, 2023 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether ImmunityBio, Inc. (“ImmunityBio,” or the “Company”) (NASDAQ: IBRX) complied with federal securities laws. On May 11, 2023, ImmunityBio disclosed that it received a comple...